Hemagen Diagnostics, Inc. is a U.S.-based provider of diagnostic solutions for clinical laboratories, blood banks and hospitals. Headquartered in Columbia, Maryland, the company develops, manufactures and markets a broad portfolio of products designed to support infectious disease testing, molecular biology research and general clinical diagnostics.
The company’s product line includes specimen collection devices, nucleic acid purification kits, immunoassays and rapid test kits. Hemagen’s proprietary extraction and purification technologies facilitate the preparation of high-quality DNA and RNA from a variety of sample types, while its reagent kits support the detection of viral, bacterial and parasitic pathogens. The firm also offers latex agglutination assays and rapid point-of-care tests for various infectious diseases.
Through a network of distribution partners, Hemagen Diagnostics serves customers across North America, Europe and the Asia-Pacific region. Its diagnostic tools are used by reference laboratories, public health institutions and commercial testing facilities seeking reliable, high-throughput solutions. By combining in-house manufacturing with third-party collaborations, the company aims to maintain consistent supply and quality standards.
With more than three decades of experience in the diagnostic industry, Hemagen Diagnostics focuses on innovation in sample processing and assay development. The company’s management team brings expertise in molecular biology and clinical testing, positioning Hemagen to address evolving laboratory needs and emerging infectious threats.
AI Generated. May Contain Errors.
